Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

NCT01821729 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: FOLFIRINOX
DRUG: Losartan
RADIATION: Proton Beam Radiation

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]